PharmaVoice 100: Page 3
-
Profile // PharmaVoice 100
Disrupters: Dr. Ian Walters
How the CEO of Portage Biotech is steering cancer R&D in a new direction by advancing diverse drug platforms.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Matt Walz
The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Sastry Chilukuri
The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Giacomo Chiesi
For the head of Chiesi Global Rare Diseases, patient centricity is in his DNA.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Jonathan Steckbeck
The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Dr. Bobak Azamian
The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Raymond Stevens
The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Ann Barnes
The CEO of Intelligent Medical Objects is growing her company’s diversity initiatives — and its bottom line.
By PharmaVoice staff • Sept. 6, 2022 -
Tracker // PharmaVoice 100
The 2022 PharmaVoice 100
From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Jeremy Levin
Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics has demonstrated that he is a patient advocate, scientist, clinician and innovator at heart.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Laxmi Bonagiri
EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Dr. Pam Diamond
The chief medical officer and co-founder of Curavit Clinical Research is bringing a new level of inclusiveness to clinical trials.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Dr. Tania Small
GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Jeanne Magram
Celsius Therapeutics’ CSO is turning ideas into approved medicines for patients with cancer and autoimmune diseases.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Kuldeep Singh Rajput
Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Dawn Barry
The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Otis Johnson
Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices.
By Karissa Waddick • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Abigail Jenkins
With the belief that empathy is critical to leadership, the former chief commercial and business officer of Lyndra Therapeutics has a strong track record of building teams and accelerating progress.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Mike Gladstone
The global president of Pfizer's Inflammation and Immunology unit is unlocking his team’s potential to meet big goals against a promising pipeline.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Sebastian Guth
Bayer Pharmaceuticals’ president, Americas Region, is driving equality efforts both within the company and for patients.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Helen Thackray
The chief research and development officer at BioCryst Pharmaceuticals is leaning into decades of experience to advance a promising pipeline of rare disease products.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Julie Kim
The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Carol Lynch
The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Lori Abrams
The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Edward Kaye
The CEO behind the first genetic therapy for Duchenne muscular dystrophy is looking to extend his winning streak at Stoke.
By PharmaVoice staff • Sept. 6, 2022